Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders.

Recs

0
Player Avatar CarlosDK (37.38) Submitted: 9/4/2012 11:26:09 AM : Outperform Start Price: $4.32 VNDA Score: -16.81

gainforbrave

Featured Broker Partners


Advertisement